Hiroshi Yagata
Kawagoe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2- Breast Cancer: A Prospective Phase II Study.
Journal: Clinical breast cancer
Published: June 23, 2020
Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer.
Journal: Surgery today
Published: August 25, 2017
Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
Journal: Clinical breast cancer
Published: March 06, 2017
Breast cancer with an extremely high Ki-67 labeling index despite a low nuclear grade.
Journal: Pathology international
Published: April 04, 2016
Malignant phyllodes tumor metastasized to the right ventricle: a case report.
Journal: Surgical case reports
Published: September 08, 2015
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Journal: Journal of surgical oncology
Published: August 13, 2015
Sustained Interruption of Anterior Interfaces Between Adipose Tissues and Mammary Glands in Ultrasonography After Complete Pathological Remission After Neoadjuvant Chemotherapy for Primary Breast Cancer.
Journal: Clinical breast cancer
Published: August 02, 2015
The accuracy of Japanese claims data in identifying breast cancer cases.
Journal: Biological & pharmaceutical bulletin
Published: March 07, 2015
Psychological impact of breast cancer screening in Japan.
Journal: International journal of clinical oncology
Published: March 04, 2015
Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: November 26, 2014
Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor-positive, lymph-node-negative early-stage breast cancer in Japan.
Journal: BMC health services research
Published: December 12, 2013
Last Updated: 09/26/2026